
Sourced report
Source11 months ago
OTC nasal spray seemed to cut COVID infections by 67% in mid-sized trial
The Phase 2 trial is not definitive, but it comes as vaccine access is severely restricted. ...
2 min briefingRead signal →
1 premium articles in this collection

The Phase 2 trial is not definitive, but it comes as vaccine access is severely restricted. ...